Evidence map›Paper›PMID 41198990›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Mapping systemic inter-organ metabolic networks across glycemic continuum using whole-body [

Xuetong Tao, Zilong Guan, Jiaxiang Qu, Qian Sun, Yong Xiao, Zhan Li, Ning Ma, Xiaohua Lin, Guanghua Wen, Hairong Zheng and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Whole-bodyEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xuetong TaoLauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Zilong GuanKey Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, 518055, China.
Jiaxiang QuKey Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, 518055, China.
Qian SunDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Yong XiaoMedical Imaging Center, Shenzhen Exit - Entry Frontier Inspection Station General Hospital, Shenzhen, 518024, China.
Zhan LiDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Ning MaDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Xiaohua LinDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Guanghua WenDepartment of Nuclear Medicine, Department of Nuclear Medicine, Shenzhen Longhua district central hospital, Shenzhen, 518100, China.
Hairong ZhengKey Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, 518055, China.
Dong LiangKey Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, 518055, China.
Na ZhangLauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Mengjie DongDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China. dmjlzf2016@zju.edu.cn.
Zhanli HuKey Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, 518055, China. zl.hu@siat.ac.cn.ORCID 0000-0003-0618-6240

Funding

National Key Research and Development Program of China 2024YFE0202400National Natural Science Foundation of China 12326607National Natural Science Foundation of China 82372038Natural Science Foundation of Guangdong Province 2023B1515120007Natural Science Foundation of Guangdong Province 2024B1515040018Shenzhen Excellent Technological Innovation Talent Training Project of China RCJC20200714114436080Shenzhen Medical Research Fund of China B2301002Shenzhen Science and Technology Program of China JCYJ20220818101804009Shenzhen Science and Technology Program of China KJZD20240903101307010
6 · The paper itself

Abstract

purposeGlucose homeostasis relies on coordinated interactions among multiple organs, and its disruption relates to diabetes development. This study investigated how inter-organ metabolic coordination, assessed by whole-body [¹⁸F]FDG PET/CT, is altered across the glycemic continuum at both the population and individual levels, and whether individualized dysfunction features can improve early diabetes risk stratification.

methodsWe analyzed whole-body [¹⁸F]FDG PET/CT scans from 1,149 adults across two independent centers, classified into normoglycemic, pre-diabetic, and diabetic groups based on fasting glucose. Standardized uptake values normalized by lean body mass were extracted from 20 major organs. These values were further adjusted for age, sex, and BMI using general linear models to reduce demographic confounding. Group-level metabolic connectivity networks were constructed using bootstrapped correlation matrices with False Discovery Rate correction. To capture individual-level dysregulation, we generated deviation networks by quantifying how each subject's inter-organ coordination diverged from demographically matched normative reference patterns. These personalized network features were used to train and validate a machine learning model for classifying pre-diabetes versus diabetes.

resultsAt the population-level, network topological analysis revealed a decline in inter-organ metabolic connectivity from normoglycemia to pre-diabetes to diabetes. Pre-diabetes was marked by widespread but modest weakening of connections across multiple organs, while diabetes showed fewer but more concentrated disruptions, indicating a shift toward localized network breakdown. Specific alterations included reduced coordination between the kidneys in pre-diabetes, and disrupted connectivity between the brain and liver in diabetes. Individualized deviation networks captured subject-level differences in metabolic connectivity, with greater heterogenity observed in pre-diabetes. A machine learning model trained on these personalized features successfully distinguished diabetes from pre-diabetes (AUC = 0.75, external validation), with brain-peripheral connections emerging as the most informative predictors.

conclusionThis study reveals distinct patterns of inter-organ matbolic connectivity breakdowns across glycemic states and demonstrates that individualized network features can effectively capture subject-specific dysregulation.

Indexed as

Blood GlucoseDiabetes MellitusFluorodeoxyglucose F18Machine LearningMetabolic Networks and PathwaysPositron Emission Tomography Computed TomographyWhole Body ImagingAdultAgedFemaleHumansMaleMiddle AgedOrgan SpecificityBlood GlucoseFluorodeoxyglucose F18Individualized deviation networkInter-organ connectivityMachine learningMetabolic networkPre-diabetesWhole-body PET/CT

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.